Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating an investigational RNA-based malaria vaccine for safety, efficacy, and immune responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• RNA-based malaria vaccine (investigational)

Snippet

Sponsor: BioNTech SE | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED